Devron R. Averett
Plus aucun poste en cours
Profil
Devron R.
Averett has been Chief Scientific Officer of Anadys Pharmaceuticals, Inc. since October 2004.
He joined Anadys Pharmaceuticals as Senior Vice President of Research, Development and Medical in 2000 and was Senior Vice President of Drug Development.
From 1996 to 1999, Dr. Averett was Senior Vice President of Research and Development for Valeant Pharmaceuticals International.
He held various positions at Glaxo Wellcome and Burroughs Wellcome Co. He received a BS degree in Chemistry and an MS degree in Microbiology from the University of Georgia and a PhD degree in Microbiology and Immunology from the University of North Carolina.
Anciens postes connus de Devron R. Averett
| Sociétés | Poste | Fin |
|---|---|---|
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Directeur Technique/Scientifique/R&D | 17/08/2007 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Formation de Devron R. Averett
| University of Georgia | Graduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Commercial Services |
